ID   KS6B1_HUMAN             Reviewed;         525 AA.
AC   P23443;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 2.
DT   05-OCT-2010, entry version 115.
DE   RecName: Full=Ribosomal protein S6 kinase beta-1;
DE            Short=S6K-beta-1;
DE            Short=S6K1;
DE            EC=2.7.11.1;
DE   AltName: Full=70 kDa ribosomal protein S6 kinase 1;
DE            Short=P70S6K1;
DE            Short=p70-S6K 1;
DE   AltName: Full=Ribosomal protein S6 kinase I;
DE   AltName: Full=Serine/threonine-protein kinase 14A;
DE   AltName: Full=p70 ribosomal S6 kinase alpha;
DE            Short=p70 S6 kinase alpha;
DE            Short=p70 S6K-alpha;
DE            Short=p70 S6KA;
GN   Name=RPS6KB1; Synonyms=STK14A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE INITIATION.
RX   MEDLINE=92017834; PubMed=1922062;
RA   Grove J., Bonerjee P., Balasubramanyam A., Coffer P., Price D.J.,
RA   Avruch J., Woodgett J.R.;
RT   "Cloning and expression of two human p70 S6 kinase polypeptides
RT   differing only at their amino termini.";
RL   Mol. Cell. Biol. 11:5541-5550(1991).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=99023916; PubMed=9804755; DOI=10.1074/jbc.273.46.30061;
RA   Gout I., Minami T., Hara K., Tsujishita Y., Filonenko V.,
RA   Waterfield M.D., Yonezawa K.;
RT   "Molecular cloning and characterization of a novel p70 S6 kinase, p70
RT   S6 kinase beta containing a proline-rich region.";
RL   J. Biol. Chem. 273:30061-30064(1998).
RN   [3]
RP   ENZYME REGULATION, PHOSPHORYLATION AT THR-252, AND MUTAGENESIS OF
RP   THR-412; SER-434; SER-441; THR-444 AND SER-447.
RX   PubMed=9445476; DOI=10.1126/science.279.5351.707;
RA   Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C.,
RA   Hemmings B.A., Thomas G.;
RT   "Phosphorylation and activation of p70s6k by PDK1.";
RL   Science 279:707-710(1998).
RN   [4]
RP   FUNCTION IN PHOSPHORYLATION OF EEF2K, AND FUNCTION IN TRANSLATION
RP   REGULATION.
RX   PubMed=11500364; DOI=10.1093/emboj/20.16.4370;
RA   Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G.;
RT   "Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6
RT   kinase.";
RL   EMBO J. 20:4370-4379(2001).
RN   [5]
RP   INTERACTION WITH RPTOR.
RX   MEDLINE=22145924; PubMed=12150926; DOI=10.1016/S0092-8674(02)00833-4;
RA   Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S.,
RA   Tokunaga C., Avruch J., Yonezawa K.;
RT   "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR
RT   action.";
RL   Cell 110:177-189(2002).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH TRAF4.
RX   PubMed=12801526; DOI=10.1016/S0145-2126(02)00325-9;
RA   Fleckenstein D.S., Dirks W.G., Drexler H.G., Quentmeier H.;
RT   "Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new
RT   binding partner for the p70S6 serine/threonine kinase.";
RL   Leuk. Res. 27:687-694(2003).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH POLDIP3.
RX   PubMed=15341740; DOI=10.1016/j.cub.2004.08.061;
RA   Richardson C.J., Broenstrup M., Fingar D.C., Julich K., Ballif B.A.,
RA   Gygi S., Blenis J.;
RT   "SKAR is a specific target of S6 kinase 1 in cell growth control.";
RL   Curr. Biol. 14:1540-1549(2004).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF EIF4B.
RX   PubMed=15071500; DOI=10.1038/sj.emboj.7600193;
RA   Raught B., Peiretti F., Gingras A.C., Livingstone M., Shahbazian D.,
RA   Mayeur G.L., Polakiewicz R.D., Sonenberg N., Hershey J.W.;
RT   "Phosphorylation of eucaryotic translation initiation factor 4B Ser422
RT   is modulated by S6 kinases.";
RL   EMBO J. 23:1761-1769(2004).
RN   [9]
RP   FUNCTION IN CELL CYCLE PROGRESSION.
RX   PubMed=14673156; DOI=10.1128/MCB.24.1.200-216.2004;
RA   Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C.,
RA   Blenis J.;
RT   "mTOR controls cell cycle progression through its cell growth
RT   effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor
RT   4E.";
RL   Mol. Cell. Biol. 24:200-216(2004).
RN   [10]
RP   FUNCTION IN TRANSLATION INITIATION, INTERACTION WITH EIF3B AND EIF3C,
RP   AND MUTAGENESIS OF THR-412.
RX   PubMed=16286006; DOI=10.1016/j.cell.2005.10.024;
RA   Holz M.K., Ballif B.A., Gygi S.P., Blenis J.;
RT   "mTOR and S6K1 mediate assembly of the translation preinitiation
RT   complex through dynamic protein interchange and ordered
RT   phosphorylation events.";
RL   Cell 123:569-580(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND
RP   SER-447, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF GSK3B.
RX   PubMed=17052453; DOI=10.1016/j.molcel.2006.09.019;
RA   Zhang H.H., Lipovsky A.I., Dibble C.C., Sahin M., Manning B.D.;
RT   "S6K1 regulates GSK3 under conditions of mTOR-dependent feedback
RT   inhibition of Akt.";
RL   Mol. Cell 24:185-197(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=17053147; DOI=10.1126/science.1130276;
RA   Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H.,
RA   Sherman N.E., Pagano M.;
RT   "S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein
RT   translation and cell growth.";
RL   Science 314:467-471(2006).
RN   [15]
RP   ENZYME REGULATION, AND MUTAGENESIS OF LYS-167 AND SER-394.
RX   PubMed=17446865; DOI=10.1038/sj.emboj.7601682;
RA   Hauge C., Antal T.L., Hirschberg D., Doehn U., Thorup K.,
RA   Idrissova L., Hansen K., Jensen O.N., Jorgensen T.J., Biondi R.M.,
RA   Frodin M.;
RT   "Mechanism for activation of the growth factor-activated AGC kinases
RT   by turn motif phosphorylation.";
RL   EMBO J. 26:2251-2261(2007).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF RMP, AND SUBCELLULAR LOCATION.
RX   PubMed=17936702; DOI=10.1016/j.molcel.2007.08.010;
RA   Djouder N., Metzler S.C., Schmidt A., Wirbelauer C., Gstaiger M.,
RA   Aebersold R., Hess D., Krek W.;
RT   "S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes
RT   activates a negative feedback program that counters S6K1 survival
RT   signaling.";
RL   Mol. Cell 28:28-40(2007).
RN   [17]
RP   PHOSPHORYLATION AT THR-412.
RX   PubMed=18925875; DOI=10.1042/BJ20081668;
RA   Garcia-Martinez J.M., Alessi D.R.;
RT   "mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation
RT   and activation of serum- and glucocorticoid-induced protein kinase 1
RT   (SGK1).";
RL   Biochem. J. 416:375-385(2008).
RN   [18]
RP   FUNCTION IN PHOSPHORYLATION OF IRS1, FUNCTION IN GLUCOSE HOMEOSTASIS,
RP   AND INTERACTION WITH IRS1.
RX   PubMed=18952604; DOI=10.1074/jbc.M806480200;
RA   Zhang J., Gao Z., Yin J., Quon M.J., Ye J.;
RT   "S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin
RT   resistance in response to TNF-(alpha) signaling through IKK2.";
RL   J. Biol. Chem. 283:35375-35382(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND
RP   SER-447, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   FUNCTION, ALTERNATIVE SPLICING, PHOSPHORYLATION AT SER-394; THR-412;
RP   THR-444 AND SER-447, AND SUBCELLULAR LOCATION.
RX   PubMed=19085255; DOI=10.1080/08977190802556986;
RA   Kim D., Akcakanat A., Singh G., Sharma C., Meric-Bernstam F.;
RT   "Regulation and localization of ribosomal protein S6 kinase 1
RT   isoforms.";
RL   Growth Factors 27:12-21(2009).
RN   [21]
RP   ENZYME REGULATION, AND MUTAGENESIS OF THR-412.
RX   PubMed=19570988; DOI=10.1074/jbc.M109.032177;
RA   Keshwani M.M., Gao X., Harris T.K.;
RT   "Mechanism of PDK1-catalyzed Thr-229 phosphorylation of the S6K1
RT   protein kinase.";
RL   J. Biol. Chem. 284:22611-22624(2009).
RN   [22]
RP   FUNCTION IN PHOSPHORYLATION OF RICTOR.
RX   PubMed=19720745; DOI=10.1128/MCB.00735-09;
RA   Dibble C.C., Asara J.M., Manning B.D.;
RT   "Characterization of Rictor phosphorylation sites reveals direct
RT   regulation of mTOR complex 2 by S6K1.";
RL   Mol. Cell. Biol. 29:5657-5670(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND
RP   SER-447, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   FUNCTION IN PHOSPHORYLATION OF RICTOR.
RX   PubMed=19995915; DOI=10.1128/MCB.00601-09;
RA   Julien L.A., Carriere A., Moreau J., Roux P.P.;
RT   "mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and
RT   regulates mTORC2 signaling.";
RL   Mol. Cell. Biol. 30:908-921(2010).
RN   [26]
RP   FUNCTION IN PHOSPHORYLATION OF RICTOR.
RX   PubMed=19935711; DOI=10.1038/onc.2009.401;
RA   Treins C., Warne P.H., Magnuson M.A., Pende M., Downward J.;
RT   "Rictor is a novel target of p70 S6 kinase-1.";
RL   Oncogene 29:1003-1016(2010).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 75-399.
RX   PubMed=19864428; DOI=10.1074/jbc.M109.040667;
RA   Sunami T., Byrne N., Diehl R.E., Funabashi K., Hall D.L., Ikuta M.,
RA   Patel S.B., Shipman J.M., Smith R.F., Takahashi I., Zugay-Murphy J.,
RA   Iwasawa Y., Lumb K.J., Munshi S.K., Sharma S.;
RT   "Structural basis of human p70 ribosomal S6 kinase-1 regulation by
RT   activation loop phosphorylation.";
RL   J. Biol. Chem. 285:4587-4594(2010).
RN   [28]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-289.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [29]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-225; CYS-272; CYS-276 AND ALA-398.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts to integrate nutrient and growth factor signals in
CC       regulation of protein synthesis, cell proliferation, cell growth,
CC       cell cycle progression and cell survival. Downstream effector of
CC       the mTOR signaling pathway. Phosphorylates specifically ribosomal
CC       protein S6 in response to insulin or several classes of mitogens.
CC       During translation initiation, the inactive form associatess with
CC       the eIF-3 complex under conditions of nutrient depletion.
CC       Mitogenic stimulation leads to phosphorylation and dissociation
CC       from the eIF-3 complex and the free activated form can
CC       phosphorylate other translational targets including EIF4B.
CC       Promotes protein synthesis by phosphorylating PDCD4 at 'Ser-67'
CC       and targeting it for degradation. Phosphorylates RICTOR leading to
CC       regulation of mammalian target of rapamycin complex 2 (mTORC2)
CC       signaling; probably phosphorylates RICTOR at 'Thr-1135'.
CC       Phosphorylates IRS1 at multiple serine residues coupled with
CC       insulin resistance; probably phosphorylates IRS1 at 'Ser-270'.
CC       Required for TNF-alpha induced IRS-1 degradation. Phosphorylates
CC       EEF2K in response to IGF1 and inhibits EEF2K activity.
CC       Phosphorylates BAD at 'Ser-99' in response to IGF1 leading to BAD
CC       inactivation and inhibition of BAD-induced apoptosis.
CC       Phosphorylates mitochondrial RMP leading to dissociation of a
CC       RMP:PPP1CC complex; probably phosphorylates RMP at 'Ser-99'. The
CC       free mitochondrial PPP1CC can dephosphorylate RPS6KB1 at Thr-412
CC       which is proposed to be a negative feed back mechanism for the
CC       RPS6KB1 antiapoptotic function. Phosphorylates GSK3B at 'Ser-9'
CC       under conditions leading to loss of the TSC1-TSC2 complex.
CC       Phosphorylates POLDIP3.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by serine/threonine phosphorylation
CC       and protein kinase C, inactivated by type 2A phosphatase.
CC       Activation requires multiple phosphorylatiopn events. Activation
CC       appears to be first mediated by multiple phosphorylation in the
CC       autoinhibitory domain, which facilitates phosphorylation at Thr-
CC       412 by disrupting the autoinhibitory mechanism and allowing
CC       phosphorylation of Thr-252. The active conformation of the kinase
CC       is believed to be stablilized by a mechanism involving three
CC       conserved phosphorylation sites located in the kinase domain
CC       activation loop (Thr-252) and in the AGC-kinase C-terminal domain
CC       (Ser-394 in the middle of the tail/linker region and Thr-412
CC       within a hydrophobic motif at its end). Activated by mTORC1;
CC       isoform Alpha I and isoform Alpha II are sensitive for rapamycin,
CC       which inhibits phosphorylation at Thr-412. Activated by PDPK1.
CC   -!- SUBUNIT: Interacts with PPP1R9A/neurabin-1 (By similarity).
CC       Interacts with RPTOR. Interacts with IRS1. Interacts with EIF3B
CC       and EIF3C. Interacts with POLDIP3 and TRAF4.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, synaptosome (By
CC       similarity). Mitochondrion outer membrane.
CC   -!- SUBCELLULAR LOCATION: Isoform Alpha I: Nucleus. Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform Alpha II: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist;
CC       Name=Alpha I; Synonyms=p80-S6K 1;
CC         IsoId=P23443-1; Sequence=Displayed;
CC       Name=Alpha II;
CC         IsoId=P23443-2; Sequence=VSP_018839;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DOMAIN: The autoinhibitory domain is believed to block
CC       phosphorylation within the AGC-kinase C-terminal domain and the
CC       activation loop.
CC   -!- DOMAIN: The TOS (TOR signaling) motif is essential for activation
CC       by mTORC1 (By similarity).
CC   -!- PTM: Phosphorylation at Thr-412 is regulated by mTORC1. The
CC       phosphorylation at this site is maintained by an agonist-dependent
CC       autophosphorylation mechanism (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60724; AAA36410.1; -; mRNA.
DR   EMBL; M60725; AAA36411.1; -; mRNA.
DR   IPI; IPI00216132; -.
DR   IPI; IPI00759649; -.
DR   PIR; A41687; A41687.
DR   RefSeq; NP_003152.1; -.
DR   UniGene; Hs.463642; -.
DR   PDB; 3A60; X-ray; 2.80 A; A/B=75-399.
DR   PDB; 3A61; X-ray; 3.43 A; A=75-399.
DR   PDB; 3A62; X-ray; 2.35 A; A=75-399.
DR   PDBsum; 3A60; -.
DR   PDBsum; 3A61; -.
DR   PDBsum; 3A62; -.
DR   ProteinModelPortal; P23443; -.
DR   SMR; P23443; 90-420.
DR   DIP; DIP-29986N; -.
DR   MINT; MINT-203709; -.
DR   STRING; P23443; -.
DR   PhosphoSite; P23443; -.
DR   PRIDE; P23443; -.
DR   Ensembl; ENST00000225577; ENSP00000225577; ENSG00000108443.
DR   GeneID; 6198; -.
DR   KEGG; hsa:6198; -.
DR   UCSC; uc002ixy.1; human.
DR   CTD; 6198; -.
DR   GeneCards; GC17P057970; -.
DR   H-InvDB; HIX0014049; -.
DR   HGNC; HGNC:10436; RPS6KB1.
DR   HPA; CAB003838; -.
DR   HPA; CAB018346; -.
DR   MIM; 608938; gene.
DR   PharmGKB; PA34851; -.
DR   eggNOG; prNOG13558; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P23443; -.
DR   OMA; DELEEGX; -.
DR   OrthoDB; EOG99W51J; -.
DR   PhylomeDB; P23443; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; il2_pi3kpathway; IL2 signaling events mediated by PI3K.
DR   Pathway_Interaction_DB; il4_2pathway; IL4-mediated signaling events.
DR   Pathway_Interaction_DB; insulin_pathway; Insulin Pathway.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; telomerasepathway; Regulation of Telomerase.
DR   Pathway_Interaction_DB; rxr_vdr_pathway; RXR and RAR hetrodimerization with other nuclear receptor.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; kitpathway; Signaling events mediated by Stem cell factor receptor (c-Kit).
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   NextBio; 24073; -.
DR   ArrayExpress; P23443; -.
DR   Bgee; P23443; -.
DR   CleanEx; HS_RPS6KB1; -.
DR   Genevestigator; P23443; -.
DR   GermOnline; ENSG00000108443; Homo sapiens.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-KW.
DR   GO; GO:0019717; C:synaptosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptosis; IMP:UniProtKB.
DR   GO; GO:0048015; P:phosphoinositide-mediated signaling; TAS:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045948; P:positive regulation of translational initia...; IMP:UniProtKB.
DR   GO; GO:0031929; P:TOR signaling cascade; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016238; Ribosomal_S6_kinase.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000605; Ribsml_S6_kin_1; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Apoptosis;
KW   ATP-binding; Cell cycle; Cell junction; Complete proteome; Cytoplasm;
KW   Kinase; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Synapse; Synaptosome; Transferase;
KW   Translation regulation.
FT   CHAIN         1    525       Ribosomal protein S6 kinase beta-1.
FT                                /FTId=PRO_0000024342.
FT   DOMAIN       91    352       Protein kinase.
FT   DOMAIN      353    423       AGC-kinase C-terminal.
FT   NP_BIND      97    105       ATP (By similarity).
FT   REGION      424    525       Autoinhibitory domain.
FT   MOTIF        28     32       TOS motif.
FT   ACT_SITE    218    218       Proton acceptor (By similarity).
FT   BINDING     123    123       ATP (By similarity).
FT   MOD_RES     252    252       Phosphothreonine; by PDPK1 (Probable).
FT   MOD_RES     304    304       N6-acetyllysine.
FT   MOD_RES     394    394       Phosphoserine.
FT   MOD_RES     412    412       Phosphothreonine.
FT   MOD_RES     441    441       Phosphoserine.
FT   MOD_RES     444    444       Phosphothreonine.
FT   MOD_RES     447    447       Phosphoserine.
FT   VAR_SEQ       1     23       Missing (in isoform Alpha II).
FT                                /FTId=VSP_018839.
FT   VARIANT     225    225       M -> I.
FT                                /FTId=VAR_040639.
FT   VARIANT     272    272       R -> C.
FT                                /FTId=VAR_040640.
FT   VARIANT     276    276       W -> C.
FT                                /FTId=VAR_040641.
FT   VARIANT     289    289       G -> E (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035628.
FT   VARIANT     398    398       S -> A.
FT                                /FTId=VAR_040642.
FT   MUTAGEN     167    167       K->N: Greatly reduces activity. Greatly
FT                                reduces phosphorylation at T-412 and
FT                                moderately reduces phosphorylation at T-
FT                                252.
FT   MUTAGEN     394    394       S->A: Loss of activity. Loss of
FT                                phosphorylation at T-412.
FT   MUTAGEN     412    412       T->E: Mimics phosphorylation. Facilitates
FT                                phosphorylation of T-252 by PDPK1; when
FT                                associated with E-434; E-441; E-444 and
FT                                E-447. Mimics phosphorylation. No effect
FT                                on interaction with PDPK1 and
FT                                phosphorylation of T-252. Impairs
FT                                association with the eIF3 complex.
FT   MUTAGEN     434    434       S->E: Facilitates phosphorylation of T-
FT                                252 by PDPK1; when associated with E-412;
FT                                E-441; E-444 and E-447.
FT   MUTAGEN     441    441       S->E: Facilitates phosphorylation of T-
FT                                252 by PDPK1; when associated with E-412;
FT                                E-434; E-444 and E-447.
FT   MUTAGEN     444    444       T->E: Facilitates phosphorylation of T-
FT                                252 by PDPK1; when associated with E-412;
FT                                E-434; E-441 and E-447.
FT   MUTAGEN     447    447       S->E: Facilitates phosphorylation of T-
FT                                252 by PDPK1; when associated with E-412;
FT                                E-434; E-441 and E-444.
SQ   SEQUENCE   525 AA;  59140 MW;  2C3BA13CCDAF4AB3 CRC64;
     MRRRRRRDGF YPAPDFRDRE AEDMAGVFDI DLDQPEDAGS EDELEEGGQL NESMDHGGVG
     PYELGMEHCE KFEISETSVN RGPEKIRPEC FELLRVLGKG GYGKVFQVRK VTGANTGKIF
     AMKVLKKAMI VRNAKDTAHT KAERNILEEV KHPFIVDLIY AFQTGGKLYL ILEYLSGGEL
     FMQLEREGIF MEDTACFYLA EISMALGHLH QKGIIYRDLK PENIMLNHQG HVKLTDFGLC
     KESIHDGTVT HTFCGTIEYM APEILMRSGH NRAVDWWSLG ALMYDMLTGA PPFTGENRKK
     TIDKILKCKL NLPPYLTQEA RDLLKKLLKR NAASRLGAGP GDAGEVQAHP FFRHINWEEL
     LARKVEPPFK PLLQSEEDVS QFDSKFTRQT PVDSPDDSTL SESANQVFLG FTYVAPSVLE
     SVKEKFSFEP KIRSPRRFIG SPRTPVSPVK FSPGDFWGRG ASASTANPQT PVEYPMETSG
     IEQMDVTMSG EASAPLPIRQ PNSGPYKKQA FPMISKRPEH LRMNL
//
